← Open Payments lookup

SUSAN COBB: Open Payments

NPI 1336342294 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$779 in 31 payments from 10 companies in 2025. Trend: 2023 $1,000 · 2024 $862 · 2025 $779

Food & beverage: $779
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP5$294
Novo Nordisk Inc10$193
Lilly USA, LLC5$81
GlaxoSmithKline, LLC.3$60
Exact Sciences Corporation2$37
Boehringer Ingelheim Pharmaceuticals, Inc.2$32
BETA BIONICS, INC.1$26
Abbott Laboratories1$23
Phathom Pharmaceuticals, Inc.1$17
ABBVIE INC.1$17

Products named: TEZSPIRE, Rybelsus, MOUNJARO, Wegovy, TRELEGY ELLIPTA, Cologuard Collection Kit, Ozempic, iLet Bionic Pancreas.

Industry payments across TX — which companies pay providers there.